Early identification may lead to early, more effective treatment
For the first time, an international team of scientists, led by researchers at University of California San Diego School of Medicine, have determined that an Alzheimer’s disease (AD) polygenic risk score can be used to correctly identify adults with mild cognitive impairment (MCI) who were only in their 50s. MCI is considered a precursor to AD.
Purdue researcher Luis Solorio has helped create a lifelike cancer environment out of polymer to better predict how drugs might stop its course.
A study of four medical marijuana outlets in California suggests that many of their customers don’t fit the profile expected for businesses focused on sick patients.
A protein involved in cognition and storing long-term memories looks and acts like a protein from viruses. The protein, called Arc, has properties similar to those that viruses use for infecting host cells, and originated from a chance evolutionary event that occurred hundreds of millions of years ago.
When viruses infect the body’s cells, those cells face a difficult problem. How can they destroy viruses without harming themselves? Scientists at University of Utah Health have found an answer by visualizing a tiny cellular machine that chops the viruses’ genetic material into bits. Their research shows how the machine detects the intruders and processes them for destruction to protect cells and prevent the spread of infection.
We and all other animals wouldn’t be here today if our planet didn’t have a lot of oxygen in its atmosphere and oceans. But how crucial were high oxygen levels to the transition from simple, single-celled life forms to the complexity we see today?We and all other animals wouldn’t be here today if our planet didn’t have a lot of oxygen in its atmosphere and oceans. But how crucial were high oxygen levels to the transition from simple, single-celled life forms to the complexity we see today?
Vision scientists at UC Berkeley and the University of Toronto have discovered that naturally occurring molecules known as lipid mediators have the potential to halt the progression of glaucoma, the world’s second-leading cause of blindness.